Please login to the form below

Not currently logged in
Email:
Password:

Acino

This page shows the latest Acino news and features for those working in and with pharma, biotech and healthcare.

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover

Acino will acquire the rights, title and interest to the products included in the agreed portfolio, exclusive to the selected countries. ... We are confident that Acino is best positioned to provide uninterrupted access and supply of the divested

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    440. Acino / Avista Capital and Nordic Capital. Acquisition. Portfolio of drug delivery products (marketed).

  • Pharma deals during October 2013 Pharma deals during October 2013

    The other major deal featuring PE is the acquisition of Acino by Avista Capital Partners and Nordic Capital for $439m. ... share. The sale has been strongly supported by the Acino Board, notably the stock had fallen by 62 per cent over the last five years

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics